Difference between revisions of "Pharm Tech Minutes 2013.10.10"

From IHE Wiki
Jump to navigation Jump to search
Line 14: Line 14:
 
::* PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc]
 
::* PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-03.doc]
  
CP to CMPD alongside PML and request for approval for ballot ==
 
 
* Current version of CP
 
* Current version of CP
 
:* Workflow for Medication List
 
:* Workflow for Medication List
 
::* CP to CMPD alongside to PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc]
 
::* CP to CMPD alongside to PML profile: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v2.doc]
  
* Both items have been discussed
+
* Discussion
* CP has been changed (added query parameters on last page)
+
:* Both items have been discussed
:* New version: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc]
+
:* Michael Tan: Discussion of slide deck about Netherlands requirements
 +
::* [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/Requirements%20in%20NL.pptx ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/Requirements%20in%20NL.pptx]
 +
::* Netherlands require seperate collections of Prescription- and Dispense items
 +
::* CP has been extended to meet this requirements (last page)
 +
:* CP has been changed (added query parameters on last page)
 +
::* New version: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/CP-PHARM-056v3.doc]
 +
:* PML has been changed minor (typo)
 +
::* New version: [ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-10.doc ftp://ftp.ihe.net/Pharmacy/yr5_2013-2014/Technical_Committee/Profiles/MedicationList/IHE_Pharmacy_Suppl_PML_PC_2013-10-10.doc]
 +
 
 
* Decisions
 
* Decisions
 
:* Both PML profile and CP-PHARM-056 belong together and shall be treated as bundle
 
:* Both PML profile and CP-PHARM-056 belong together and shall be treated as bundle
 
:* PML profile proposal is approved and will be prepared for Public Comment
 
:* PML profile proposal is approved and will be prepared for Public Comment
 
:* CP will be further discussed
 
:* CP will be further discussed
 
  
 
== New incoming CP and request for approval for ballot ==
 
== New incoming CP and request for approval for ballot ==

Revision as of 09:06, 10 October 2013

Participants

  • Jürgen Brandstätter (CodeWerk)
  • Michael Tan (Nictiz)
  • Simon Lettelier (EAHP)
  • Stephen Chu (NEHTA)
  • Jose Costa Teixeira (Agfa)
  • Marco Demarmels
  • Vincent van Pelt (Nictiz)
  • Jacqueline Surugue (EAHP)

Review of the PML profile proposal and CP to CMPD alongside PML

  • Current version of PML profile
  • Content structure of Medication List
  • Current version of CP
  • Workflow for Medication List
  • Discussion
  • Both items have been discussed
  • Michael Tan: Discussion of slide deck about Netherlands requirements
  • CP has been changed (added query parameters on last page)
  • PML has been changed minor (typo)
  • Decisions
  • Both PML profile and CP-PHARM-056 belong together and shall be treated as bundle
  • PML profile proposal is approved and will be prepared for Public Comment
  • CP will be further discussed

New incoming CP and request for approval for ballot

  • CP-PHARM-057: Use of nullFlavor if no code/brand name of medicine is available
  • CP-PHARM-058: Relax usage of UCUM from SHALL to SHOULD


Review of CPs and request for approval for ballot

  • CP-PHARM-045: Add new implementation scenario “Usage of XDW versus database backend”
  • No change to last time
  • CP-PHARM-046: PHARM-1: New Query “FindPrescriptions”
  • No change to last time
  • CP-PHARM-047: PHARM-1: New Query “FindDispenses”
  • No change to last time
  • CP-PHARM-048: Introduce “repeatNumber” for number of allowed dispenses (Number of repeats)
  • Minor change to last time
  • CP-PHARM-049: Relieve optionality at active ingredients
  • Minor change to last time
  • CP-PHARM-050: Rule for “non-dispense”
  • No change to last time
  • CP-PHARM-051: Relieve the constraint that the whole Presciption item has to be embedded
  • Minor change to last time
  • CP-PHARM-052: Relieve the constraint that the whole Presciption item has to be embedded
  • Minor change to last time
  • CP-PHARM-053: Relieve the constraint that the whole Pharmaceutical Advice item has to be embedded
  • No change to last time
  • CP-PHARM-054: PADV can also reference to Dispense Items (not only Prescription Items)
  • Major change to last time
  • CP-PHARM-055: CMPD Maintenance
  • Major change to last time
  • All CPs are now located at FTP:


Pharmacy Technical Committee